Use and treatment modalities for SSRI and SNRI antidepressants in Italy during the period 2003–2009

References

• Available at: http://www.surgeongeneral.gov/library/mentalhealth/ [Last accessed August 2011]
   Google Scholar
• Nandi A, Beard JR, Galea S. Epidemiologic heterogeneity of common mood and anxiety disorders over the life course in the general population: a systematic review. BMC Psychiatry 2009;9:31
   PubMed Web of Science ®Google Scholar
• Berardi D, Leggieri G, Berti ceroni G, et al. Depression in primary care. A nationwide epidemiological survey. Family Practice 2002;19:397-400
   PubMed Web of Science ®Google Scholar
• Available at: http://www.epicentro.iss.it/temi/mentale/esemed-pres.asp [Last accessed August 2011]
   Google Scholar
• Eric Wua, Paul Greenberga, Elaine Yanga, et al. Comparison of treatment persistence, hospital utilization and costs among major depressive disorder geriatric patients treated with escitalopram versus other SSRI/SNRI antidepressants. Curr Med Res Opin 2008;24:2805-13
   PubMed Web of Science ®Google Scholar
• Wu EQ, Greenberg PE, Yang E, et al. Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs. J Med Econom 2009;12: 124-35
   PubMedGoogle Scholar
• Weilburg JB. An overview of SSRI and SNRI therapies for depression. Manag Care 2004;13(6 Suppl):25-33
   PubMedGoogle Scholar
• Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:85-102
   PubMed Web of Science ®Google Scholar
• Isacsson G, Boethius G, Henriksson S, et al. Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database. J Affect Disord 1999;53:15-22
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465-75
   PubMed Web of Science ®Google Scholar
• Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol 2010;45:47-56
   PubMed Web of Science ®Google Scholar
• Bauer M, Bschor T, Pfennig A, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67-104
   PubMed Web of Science ®Google Scholar
• Ereshefsky L, Saragoussi D, Despiegel N, et al. The 6-month persistence on SSRIs and associated economic burden. J Med Econ 2010;13:527-36
   PubMedGoogle Scholar
• Ufer M, Meyer SA, Junge O, et al. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Pharmacoepidemiol Drug Saf 2007;16:1153-60
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Bonnewyn A, Bruffaerts R, et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: results from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disord 2008;110:84-93
   PubMed Web of Science ®Google Scholar
• Trifiro G, Barbui C, Spina E, et al. Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003–2004. Pharmacoepidemiol Drug Saf 2007;16:552-9
   PubMed Web of Science ®Google Scholar
• Weissman J, Meyers BS, Ghosh S, et al. Sociodemographic and clinical factors associated with antidepressant type in a national sample of the home health care elderly. Gen Hosp Psychiatry 2011;33:587-93
   PubMed Web of Science ®Google Scholar
• Rich CL, Isacsson G. Suicide and antidepressants in south Alabama: evidence for improved treatment of depression. J Affect Disord 1997;45:135-42
   PubMed Web of Science ®Google Scholar
• Percudani M, Barbui C, Fortino I, et al. Antidepressant drug use in Lombardy, Italy: a population-based study. J Affect Disord 2004;83:169-75
   PubMed Web of Science ®Google Scholar
• Poluzzi E, Motola D, Silvani C, et al. Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement. Eur J Clin Pharmacol 2004;59:825-31
   PubMed Web of Science ®Google Scholar
• Guaiana G, Andretta M, Griez E, et al. Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological study. Ann Gen Psychiatry 2011;10:24
   PubMed Web of Science ®Google Scholar
• Balestrieri M, Carta MG, Leonetti S, et al. Recognition of depression and appropriateness of antidepressant treatment in Italian primary care. Soc Psychiatry Psychiatr Epidemiol 2004;39:171-6
   PubMed Web of Science ®Google Scholar
• Castelpietra G, Morsanutto A, Pascolo-Fabrici E, et al. Antidepressant use and suicide prevention: a prescription database study in the region Friuli Venezia Giulia, Italy. Acta Psychiatr Scand 2008;118:382-8
   PubMed Web of Science ®Google Scholar
• Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates of chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med 2003;25:254-7
   PubMedGoogle Scholar
• Mazzaglia G, Sessa E, Samani F, et al. Use of Computerized General Practice Database for epidemiological studies in Italy: a comparative study with the official national statistics. J Epidemiol Commun Health 2004;58(Suppl 1):A133
   Google Scholar
• Filippi A, Bignamini AA, Sessa E, et al. Secondary prevention of stroke in Italy: a cross-sectional survey in family practice. Stroke 2003;34:1010-14
   PubMed Web of Science ®Google Scholar
• Filippi A, Sabatini A, Badioli L, et al. Effects of an automated electronic reminder in changing prescribing behaviour among general practitioners in Italy: an intervention trial. Diabetes Care 2003;26:1497-500
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Mantovani LG, Sturkenboom MCJM, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hyperten 2005;23:2093-100
   PubMed Web of Science ®Google Scholar
• Lucioni C, Mazzi S. Realtà prescrittiva versus standard di consumo nel campo degli inibitori della pompa protonica in Italia. PharmacoEconomics – Italian Research Articles 2003;5:3-10
   Google Scholar
• Ravasio R, Polcaro F, Fonticoli L. Analisi della prescrizione di alcuni farmaci antidepressivi in Italia durante il quinquennio 2001–2005. PharmacoEconomics – Italian Research Articles 2009;11:175-86
   Google Scholar
• Hess LM, Raebel MA, Conner DA, et al. Adherence: measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 2006;40:1280-8
   PubMed Web of Science ®Google Scholar
• Gruppo di lavoro OsMed. L’uso dei farmaci in Italia. Rapporto nazionale anno 2009. Roma: Il Pensiero Scientifico Editore, 2010. Available at: www.agenziafarmaco.it [Last accessed June 2012]
   Google Scholar
• Bauer M, Monz BU, Montejo AL, et al. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 2008;23:66-73
   PubMed Web of Science ®Google Scholar
• Trifirò G, Tillati S, Spina E, et al. A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care. Eur J Clin Pharmacol 2012preprint [Epub Ahead of print]. DOI 10.1007/s00228-012-1319-1
   Google Scholar
• Agenzia Italiana del Farmaco A. Rapporto gennaio–settembre 2010
   Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments metaanalysis. Lancet 2009;373:746-58
   PubMed Web of Science ®Google Scholar
• Andersson Sundell K, Gissler M, Petzold M, et al. Antidepressant utilization patterns and mortality in Swedish men and women aged 20–34 years. Eur J Clin Pharmacol 2011;67:169-78
   PubMed Web of Science ®Google Scholar
• Tylee A. Depression in Europe: experience from the DEPRES II survey. Depression Research in European Society. Eur Neuropsychopharmacol 2000;10(Suppl 4):S445-8
   PubMedGoogle Scholar
• Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157:1501-4
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-17
   PubMed Web of Science ®Google Scholar
• Esposito D, Wahl P, Daniel G, et al. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States. Clin Ther 2009;31:644-56
   PubMed Web of Science ®Google Scholar